$PEB
Pebblebrook Hotel Trust

2023 Q2 Form 10-Q Financial Statement

#000147409823000101 Filed on April 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $384.3M $305.7M
YoY Change -3.32% 18.46%
Cost Of Revenue $246.0M $214.3M
YoY Change 7.72% 22.91%
Gross Profit $138.3M $91.41M
YoY Change -18.22% 9.2%
Gross Profit Margin 35.99% 29.9%
Selling, General & Admin $40.77M $38.89M
YoY Change -4.53% -3.17%
% of Gross Profit 29.48% 42.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $57.96M $58.37M
YoY Change -3.84% -1.24%
% of Gross Profit 41.9% 63.85%
Operating Expenses $98.73M $97.26M
YoY Change -4.13% -2.02%
Operating Profit $39.58M $5.202M
YoY Change -23.79% -106.7%
Interest Expense -$29.54M $27.43M
YoY Change -227.56% 21.52%
% of Operating Profit -74.64% 527.3%
Other Income/Expense, Net $952.0K $183.0K
YoY Change 6700.0% 863.16%
Pretax Income $46.21M -$22.05M
YoY Change 60.48% -78.0%
Income Tax $31.00K $0.00
% Of Pretax Income 0.07%
Net Earnings $33.45M -$22.93M
YoY Change 19.52% -76.96%
Net Earnings / Revenue 8.7% -7.5%
Basic Earnings Per Share $0.27 -$0.27
Diluted Earnings Per Share $0.22 -$0.27
COMMON SHARES
Basic Shares Outstanding 123.1M shares 126.0M shares
Diluted Shares Outstanding 151.2M shares 125.5M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $175.6M $138.5M
YoY Change 447.81% 99.46%
Cash & Equivalents $175.6M $138.5M
Short-Term Investments
Other Short-Term Assets $121.2M $113.5M
YoY Change 42.64% 69.55%
Inventory
Prepaid Expenses
Receivables $51.58M $43.42M
Other Receivables $0.00 $0.00
Total Short-Term Assets $348.3M $295.4M
YoY Change 102.62% 66.88%
LONG-TERM ASSETS
Property, Plant & Equipment $5.714B $5.703B
YoY Change -5.38% -4.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.74M $78.89M
YoY Change -93.95% 197.63%
Total Long-Term Assets $5.725B $5.782B
YoY Change -7.91% -3.67%
TOTAL ASSETS
Total Short-Term Assets $348.3M $295.4M
Total Long-Term Assets $5.725B $5.782B
Total Assets $6.073B $6.078B
YoY Change -4.94% -1.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $215.5M $216.0M
YoY Change -1.52% 13.05%
Accrued Expenses $328.6M $329.8M
YoY Change 1.07% 0.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $637.5M $640.5M
YoY Change 0.95% 5.15%
LONG-TERM LIABILITIES
Long-Term Debt $2.432B $2.431B
YoY Change -5.01% -2.19%
Other Long-Term Liabilities $0.00 $2.214M
YoY Change -100.0%
Total Long-Term Liabilities $2.432B $2.433B
YoY Change -5.19% -2.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $637.5M $640.5M
Total Long-Term Liabilities $2.432B $2.433B
Total Liabilities $3.159B $3.074B
YoY Change -1.17% -0.67%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.201M $1.236M
YoY Change -8.25% -5.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.914B $2.916B
YoY Change
Total Liabilities & Shareholders Equity $6.073B $6.078B
YoY Change -4.94% -1.64%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $33.45M -$22.93M
YoY Change 19.52% -76.96%
Depreciation, Depletion And Amortization $57.96M $58.37M
YoY Change -3.84% -1.24%
Cash From Operating Activities $73.99M $46.23M
YoY Change -28.71% 19.05%
INVESTING ACTIVITIES
Capital Expenditures $65.37M $35.06M
YoY Change -389.98% -275.72%
Acquisitions
YoY Change
Other Investing Activities $95.53M $548.0K
YoY Change -154.84% 1065.96%
Cash From Investing Activities $30.16M $105.2M
YoY Change -115.33% -627.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $498.0K
YoY Change 53.7%
Cash From Financing Activities -64.41M -$57.13M
YoY Change -207.75% 276.49%
NET CHANGE
Cash From Operating Activities 73.99M $46.23M
Cash From Investing Activities 30.16M $105.2M
Cash From Financing Activities -64.41M -$57.13M
Net Change In Cash 39.74M $94.28M
YoY Change -219.84% 2443.98%
FREE CASH FLOW
Cash From Operating Activities $73.99M $46.23M
Capital Expenditures $65.37M $35.06M
Free Cash Flow $8.621M $11.17M
YoY Change -93.18% -81.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001474098
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#RealEstateInvestmentPropertyNet
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#RealEstateInvestmentPropertyNet
CY2022Q4 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023Q1 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023Q1 us-gaap Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
0.0392549
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-34571
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
PEBBLEBROOK HOTEL TRUST
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1055421
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4747 Bethesda Avenue
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1100
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
CY2023Q1 dei City Area Code
CityAreaCode
(240)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
507-1300
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
123114013 shares
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5703446000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5874876000 usd
CY2023Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
70859000 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
44861000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138515000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41040000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8034000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
11229000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
292000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
431000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
43422000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
45258000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
113459000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
116276000 usd
CY2023Q1 us-gaap Assets
Assets
6077735000 usd
CY2022Q4 us-gaap Assets
Assets
6133540000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2388017000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2387293000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
258934000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
250518000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
320469000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
320402000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
82450000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
73603000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
9359000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4535000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
2214000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
428000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
12181000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
12218000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
3073624000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3048997000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
715000000 usd
CY2022Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
715000000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
28600000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
28600000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
28600000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
28600000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
286000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
286000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123632667 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123632667 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126345293 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126345293 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1236000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1263000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4142491000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4182359000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29891000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
35724000 usd
CY2023Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1258275000 usd
CY2022Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1223117000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2915629000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2996515000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
88482000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
88028000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3004111000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3084543000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6077735000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6133540000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
305719000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258068000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
214310000 usd
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
174360000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
58369000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
59100000 usd
CY2023Q1 peb Realestatetaxespersonalpropertytaxespropertyinsuranceandgroundrent
Realestatetaxespersonalpropertytaxespropertyinsuranceandgroundrent
28904000 usd
CY2022Q1 peb Realestatetaxespersonalpropertytaxespropertyinsuranceandgroundrent
Realestatetaxespersonalpropertytaxespropertyinsuranceandgroundrent
30457000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9988000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9708000 usd
CY2023Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
60983000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
6635000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0 usd
CY2023Q1 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
8089000 usd
CY2022Q1 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
0 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-3670000 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1123000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
300517000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
335731000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5202000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-77663000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
27430000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
22572000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
183000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22045000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-100216000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-22045000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-100216000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
883000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-686000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-22928000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-99530000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
10988000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
11344000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33916000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-110874000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125488415 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125488415 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
130904299 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
130904299 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125488415 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
130904299 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-22045000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-100216000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-46000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
27367000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
5825000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-4374000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-27916000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-68475000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-68475000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
845000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-479000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28761000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-67996000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3084543000 usd
CY2023Q1 peb Share Value Issued For Board Of Trustees Compensation
ShareValueIssuedForBoardOfTrusteesCompensation
754000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
42745000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2879000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1252000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
12152000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-46000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
5825000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-22045000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3004111000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3163905000 usd
CY2022Q1 peb Share Value Issued For Board Of Trustees Compensation
ShareValueIssuedForBoardOfTrusteesCompensation
738000 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1113000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2354000 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1131000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
11344000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
27367000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-4374000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-100216000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3084934000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-22045000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-100216000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
58369000 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
59100000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2879000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2354000 usd
CY2023Q1 peb Amortization Of Debt Issuance Costs Non Cash Interest And Other Amortization
AmortizationOfDebtIssuanceCostsNonCashInterestAndOtherAmortization
3005000 usd
CY2022Q1 peb Amortization Of Debt Issuance Costs Non Cash Interest And Other Amortization
AmortizationOfDebtIssuanceCostsNonCashInterestAndOtherAmortization
3489000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
6635000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0 usd
CY2023Q1 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
60983000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2476000 usd
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2489000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
4964000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1906000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1285000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2694000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3848000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2127000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4805000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7147000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10902000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10213000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46229000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38832000 usd
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
34514000 usd
CY2022Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
19906000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
131881000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
0 usd
CY2023Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
8357000 usd
CY2022Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
548000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
47000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
105176000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19953000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
154000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
32000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
498000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
324000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
42745000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1113000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1289000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1322000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
12152000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11344000 usd
CY2023Q1 peb Repayments Of Membership Deposits
RepaymentsOfMembershipDeposits
287000 usd
CY2022Q1 peb Repayments Of Membership Deposits
RepaymentsOfMembershipDeposits
1038000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57125000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15173000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
94280000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3706000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52269000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92247000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
146549000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95953000 usd
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
49 property
CY2023Q1 peb Number Of Guest Rooms
NumberOfGuestRooms
12451 hotelroom
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and revenues and expenses. These estimates are prepared using management’s best judgment, after considering past, current and expected events and economic conditions. Actual results could differ from these estimates.</span></div>
CY2023Q1 peb Sale Of Real Estate Held For Investment Consideration Received
SaleOfRealEstateHeldForInvestmentConsiderationReceived
135300000 usd
CY2023Q1 us-gaap Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Before Income Tax
IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax
1100000 usd
CY2022Q1 us-gaap Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Before Income Tax
IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax
-3400000 usd
CY2023Q1 peb Sale Of Real Estate Held For Sale Number Of Properties
SaleOfRealEstateHeldForSaleNumberOfProperties
2 property
CY2023Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
97000000 usd
CY2023Q1 us-gaap Land
Land
860206000 usd
CY2022Q4 us-gaap Land
Land
897756000 usd
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
5037815000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
5170976000 usd
CY2023Q1 peb Furniture Fixtures And Equipment
FurnitureFixturesAndEquipment
498010000 usd
CY2022Q4 peb Furniture Fixtures And Equipment
FurnitureFixturesAndEquipment
504518000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
91181000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
91181000 usd
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
23736000 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
11961000 usd
CY2023Q1 peb Real Estate Investment Property Excluding Operating Lease Right Of Use Asset At Cost
RealEstateInvestmentPropertyExcludingOperatingLeaseRightOfUseAssetAtCost
6510948000 usd
CY2022Q4 peb Real Estate Investment Property Excluding Operating Lease Right Of Use Asset At Cost
RealEstateInvestmentPropertyExcludingOperatingLeaseRightOfUseAssetAtCost
6676392000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
367976000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
370383000 usd
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6878924000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
7046775000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1175478000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1171899000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5703446000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5874876000 usd
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
61000000 usd
CY2022Q1 peb Impairment Of Real Estate Number Of Properties
ImpairmentOfRealEstateNumberOfProperties
2 property
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
320500000 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
42900000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
320400000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
42700000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2400487000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2400985000 usd
CY2023Q1 peb Debt Instrument Unamortized Discount Premium Net And Deferred Financing Costs Net
DebtInstrumentUnamortizedDiscountPremiumNetAndDeferredFinancingCostsNet
12470000 usd
CY2022Q4 peb Debt Instrument Unamortized Discount Premium Net And Deferred Financing Costs Net
DebtInstrumentUnamortizedDiscountPremiumNetAndDeferredFinancingCostsNet
13692000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2388017000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2387293000 usd
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
13100000 usd
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
13100000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
12600000 usd
CY2023Q1 peb Debt Instrument Election Period Prior To Maturity Date
DebtInstrumentElectionPeriodPriorToMaturityDate
P2D
CY2023Q1 peb Debt Instrument Redemption Price To Principal Amount Percentage
DebtInstrumentRedemptionPriceToPrincipalAmountPercentage
1
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1851000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2285000 usd
CY2023Q1 peb Interest Expense Debt Other
InterestExpenseDebtOther
1055000 usd
CY2022Q1 peb Interest Expense Debt Other
InterestExpenseDebtOther
524000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
27430000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
22572000 usd
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
400000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
305719000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258068000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
28600000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
28600000 shares
CY2023Q1 peb Common Unit Redemption Rights Redemption Option Common Share Conversion Basis
CommonUnitRedemptionRightsRedemptionOptionCommonShareConversionBasis
1 shares
CY2023Q1 peb Long Term Incentive Partnership Units Outstanding
LongTermIncentivePartnershipUnitsOutstanding
858484 shares
CY2022Q4 peb Long Term Incentive Partnership Units Outstanding
LongTermIncentivePartnershipUnitsOutstanding
727208 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1454457 shares
CY2023Q1 peb Long Term Incentive Partnership Units Outstanding
LongTermIncentivePartnershipUnitsOutstanding
858484 shares
CY2022Q4 peb Long Term Incentive Partnership Units Outstanding
LongTermIncentivePartnershipUnitsOutstanding
727208 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33916000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-110874000 usd
CY2023Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
11000 usd
CY2022Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
10000 usd
CY2023Q1 peb Net Income Loss Available To Common Stockholders Less Dividends And Undistributed Earnings
NetIncomeLossAvailableToCommonStockholdersLessDividendsAndUndistributedEarnings
-33927000 usd
CY2022Q1 peb Net Income Loss Available To Common Stockholders Less Dividends And Undistributed Earnings
NetIncomeLossAvailableToCommonStockholdersLessDividendsAndUndistributedEarnings
-110884000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125488415 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125488415 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
130904299 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
130904299 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2023Q1 peb Combined Base And Incentive Management Fee Expense Reversal
CombinedBaseAndIncentiveManagementFeeExpenseReversal
8000000 usd
CY2022Q1 peb Combined Base And Incentive Management Fee Expense Reversal
CombinedBaseAndIncentiveManagementFeeExpenseReversal
7700000 usd
CY2023Q1 peb Reserve Funds As Percentage Of Hotel Revenues
ReserveFundsAsPercentageOfHotelRevenues
0.040
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8000000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
11200000 usd
CY2023Q1 peb Fixed Lease Cost
FixedLeaseCost
4782000 usd
CY2022Q1 peb Fixed Lease Cost
FixedLeaseCost
4456000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
3867000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
3054000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
8649000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
7510000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
20338000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
16613000 usd
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
0 usd
CY2022Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
769000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2911000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 peb Accrued Additions And Improvements To Hotel Properties
AccruedAdditionsAndImprovementsToHotelProperties
14492000 usd
CY2022Q1 peb Accrued Additions And Improvements To Hotel Properties
AccruedAdditionsAndImprovementsToHotelProperties
2848000 usd
CY2023Q1 peb Write Off Of Fully Amortized Debt Issuance Costs
WriteOffOfFullyAmortizedDebtIssuanceCosts
0 usd
CY2022Q1 peb Write Off Of Fully Amortized Debt Issuance Costs
WriteOffOfFullyAmortizedDebtIssuanceCosts
5466000 usd

Files In Submission

Name View Source Status
0001474098-23-000101-index-headers.html Edgar Link pending
0001474098-23-000101-index.html Edgar Link pending
0001474098-23-000101.txt Edgar Link pending
0001474098-23-000101-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
peb-20230331.htm Edgar Link pending
peb-20230331.xsd Edgar Link pending
peb-20230331ex311.htm Edgar Link pending
peb-20230331ex312.htm Edgar Link pending
peb-20230331ex321.htm Edgar Link pending
peb-20230331ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
peb-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
peb-20230331_lab.xml Edgar Link unprocessable
peb-20230331_pre.xml Edgar Link unprocessable
peb-20230331_cal.xml Edgar Link unprocessable
peb-20230331_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending